MEDIKRA Trademark

Trademark Overview

On Wednesday, July 30, 2025, a trademark application was filed for MEDIKRA with the United States Patent and Trademark Office. The USPTO has given the MEDIKRA trademark a serial number of 99311617. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Monday, March 16, 2026. This trademark is owned by Medikra Inc.. The MEDIKRA trademark is filed in the Pharmaceutical Products category with the following description:

Chemical preparations for pharmaceutical purposes, namely, for use in connection with humans for the treatment of inflammatory diseases, cardio-metabolic diseases, infectious diseases, endocrinological diseases, age-related diseases, neurodegenerative diseases, oncological diseases, and men and women's general wellness and health; chemical preparations for medical purposes, namely, for use in connection with humans for the treatment of inflammatory diseases, cardio-metabolic diseases, infectious diseases, endocrinological diseases, age-related diseases, neurodegenerative diseases, oncological diseases, and men and women's general wellness and health; chemico-pharmaceutical preparations, namely, for the treatment of inflammatory diseases, cardio-metabolic diseases, infectious diseases, endocrinological diseases, age-related diseases, neurodegenerative diseases, oncological diseases, and men and women's general wellness and health; dietetic preparations adapted for medical use; digestive...
medikra

General Information

Serial Number99311617
Word MarkMEDIKRA
Filing DateWednesday, July 30, 2025
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateMonday, March 16, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesChemical preparations for pharmaceutical purposes, namely, for use in connection with humans for the treatment of inflammatory diseases, cardio-metabolic diseases, infectious diseases, endocrinological diseases, age-related diseases, neurodegenerative diseases, oncological diseases, and men and women's general wellness and health; chemical preparations for medical purposes, namely, for use in connection with humans for the treatment of inflammatory diseases, cardio-metabolic diseases, infectious diseases, endocrinological diseases, age-related diseases, neurodegenerative diseases, oncological diseases, and men and women's general wellness and health; chemico-pharmaceutical preparations, namely, for the treatment of inflammatory diseases, cardio-metabolic diseases, infectious diseases, endocrinological diseases, age-related diseases, neurodegenerative diseases, oncological diseases, and men and women's general wellness and health; dietetic preparations adapted for medical use; digestives for pharmaceutical purposes; drugs for medical purposes, namely, for the treatment of inflammatory diseases, cardio-metabolic diseases, infectious diseases, endocrinological diseases, age-related diseases, neurodegenerative diseases, oncological diseases, and men and women's general wellness and health; medical preparations for slimming purposes; pharmaceutical preparations; pharmaceuticals for the treatment and prevention of inflammatory diseases, cardio-metabolic diseases, infectious diseases, endocrinological diseases, age-related diseases, neurodegenerative diseases, oncological diseases; medicinal preparations for the mouth to be applied in the form of softgels or gelatine capsules, capsules, tablets or compressed tablets; medicinal health care preparations, namely, for the treatment of inflammatory diseases, cardio-metabolic diseases, infectious diseases, endocrinological diseases, age-related diseases, neurodegenerative diseases, oncological diseases, and men and women's general wellness and health; medicinal herbal extracts other than essential oils, for medical purposes; herbal medicine, namely, medicinal herbal preparations; herbal supplements; herbal remedies namely, for the treatment of inflammatory diseases, cardio-metabolic diseases, infectious diseases, endocrinological diseases, age-related diseases, neurodegenerative diseases, oncological diseases, and men and women's general wellness and health; plant and herb extracts other than essential oils for medicinal purposes; plant extracts other than essential oils for pharmaceutical purposes; capsules sold empty for medicines; dietary food supplements consisting of dehydrated herbal extracts in capsule form

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 30, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMedikra Inc.
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressGrand Cayman KY1-1002
KY

Trademark Events

Event DateEvent Description
Wednesday, July 30, 2025NEW APPLICATION ENTERED
Wednesday, July 30, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 30, 2025APPLICATION FILING RECEIPT MAILED
Monday, December 15, 2025ASSIGNED TO EXAMINER
Monday, December 15, 2025NON-FINAL ACTION WRITTEN
Monday, December 15, 2025NON-FINAL ACTION E-MAILED
Monday, December 15, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 16, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 16, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 16, 2026TEAS/EMAIL CORRESPONDENCE ENTERED

Related Keywords

medikra diseases preparations related neurodegenerative endocrinological oncological women health wellness general